We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
CIRS

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Transperineal Needle-Guidance System Uses MR-Ultrasound Image-Fusion Prostate Biopsy Technology

By MedImaging International staff writers
Posted on 09 Mar 2022
Print article
Image: iSR’obot Mona Lisa intelligent real-time robotic system (Photo courtesy of Biobot Surgical)
Image: iSR’obot Mona Lisa intelligent real-time robotic system (Photo courtesy of Biobot Surgical)

A new robotic assisted transperineal needle-guidance system allows urologists to plan and position a single needle or multiple needles during image-guided diagnostic and interventional prostate procedures.

The iSR'obot Mona Lisa 2.0 from Biobot Surgical (Singapore) automatically supports needle positioning during transperineal prostate biopsy and prostate cancer ablation based on a customized needle plan. The second-generation iSR'obot Mona Lisa system retains the MR-ultrasound image-fusion prostate biopsy technology. The robotic system's proprietary dual-cone needle trajectory technology enables the extraction of multiple biopsy cores through the same needle entry points. Some of the new features of the iSR'obot Mona Lisa 2.0 include a detachable needle guide that holds a biopsy needle or multiple ablation needle, visualization and planning of the needle locations for a prostate cancer ablation procedure, and the ability to re-adjust a target location when the needle deflects.

Biobot Surgical has received U.S. FDA 510(k) clearance for the iSR'obot Mona Lisa 2.0. The first-generation iSR'obot Mona Lisa is marketed in Europe, Australia, and Asia. Clinical studies have demonstrated that iSR'obot Mona Lisa has a clinically significant prostate cancer detection rate of 81% higher than cognitive fusion biopsy. Clinical data also shows that the transperineal, dual-cone needle trajectory technology minimizes infection complications.

“The Mona Lisa system was conceptualized and engineered to position biopsy or treatment needles transperineally,” said Sim Kok Hwee, CEO of Biobot Surgical. “The advantages of transperineal procedures are lower infection rates and better coverage of the anterior zone compared to transrectal procedures. In addition, most ablation procedures are also carried out transperineally. The Mona Lisa system simplifies needle positioning by providing robotic assisted guidance for the insertion.”

Related Links:
Biobot Surgical


Print article
Sun Nuclear
Radcal

Channels

Radiography

view channel
Image: CE-marked and FDA-cleared ExacTrac Dynamic enables the delivery of precision radiotherapy (Photo courtesy of Brainlab)

Next-Gen Technology Enables Precision Radiotherapy with “On-The-Fly” X-Ray Confirmation

Deep Inspiration Breath Hold (DIBH) is a well-established technique and standard of care in treating breast cancer with radiation therapy. When a patient takes a deep breath, the distance between the heart... Read more

MRI

view channel
Image: fMRI can be used as non-invasive method for predicting complications in chronic liver disease (Photo courtesy of Pexels)

Functional MRI (fMRI) Offers Non-Invasive Method for Risk Assessment in Liver Disease

In a recent study, a team of scientists has shown that functional magnetic resonance imaging (fMRI) can be used as a non-invasive method for predicting complications in chronic liver disease.... Read more

Ultrasound

view channel
Image: Resona I9 ultrasound system features innovative design elements (Photo courtesy of Mindray)

Mindray’s Latest Resona I9 Ultrasound System Provides Innovation-Driven Experience

Mindray (Shenzhen, China) has launched a new ultrasound system which provides an entirely new experience, driven by innovation to address today’s clinical challenges. Mindray’s latest Resona I9 ultrasound... Read more

Imaging IT

view channel
Illustration

Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology

The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read more

Industry News

view channel
Image: Global diagnostic imaging market is driven by technological advancements (Photo courtesy of Pexels)

Global Diagnostic Imaging Market to Surpass USD 33 Billion by 2026

The global diagnostic imaging market is one of the most critical segments of the healthcare sector. Medical imaging helps in early detection and diagnosis of diseases at a stage when they can be easily... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.